Wu Yifang, president and CEO of Shanghai Fosun Pharmaceutical Group. Photo: Handout
China’s Fosun Pharma to bypass India’s regulatory hurdles after cutting stake in Gland Pharma deal
Chinese drug maker to cut the stake it wants to buy in India’s Gland Pharma to ensure faster regulatory approvals
Wu Yifang, president and CEO of Shanghai Fosun Pharmaceutical Group. Photo: Handout